{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:02:36Z","timestamp":1760889756234},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Characterized by diffuse hepatic fibrosis and nodule formation, hepatitis B cirrhosis (HBC), an important result of chronic hepatitis B development, mainly contains compensated and decompensated stage. Compensated cirrhosis can further develop into decompensated stage and hepatocellular carcinoma with serious complications and high mortality. Antiviral therapy using interferon (IFN) or nucleos(t)ide analogs (NUCs) is essential for improving the prognosis of the disease but IFN has large side effects while NUCs often develop drug resistance. Antifibrosis is also an important strategy, but currently there is no effective antifibrosis drug. Pharmacologic studies have demonstrated that oxymatrine (OM) exhibits anti-hepatitis B virus (HBV) and antifibrosis effects. An increasing number of clinical controlled studies also have found that OM combined with conventional therapy could improve the curative effect and reduce adverse events incidence in treating HBC but there is no systematic review of it. Based on the extensive collection of literature, we will use meta-analysis to assess the efficacy and safety of OM for HBC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, MEDLINE, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang data, Chinese Scientific Journals Database (VIP), and China biomedical literature database will be searched to obtain the eligible studies published up to July 15, 2018. The primary outcome will be liver function indexes, liver fibrosis indexes, and Child\u2013Pugh score. The secondary outcome will be hepatitis B virus DNA quantification, HBV DNA seroconversion rate, hepatitis B e antigen (HBeAg) seroconversion rate, and adverse events incidence. Data analysis will be conducted using RevMan 5.3 and Stata V.9.0 software. Trial sequential analysis (TSA) will be performed to assess the risk of random error and the validity of conclusion using TSA program version 0.9 beta.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This systematic review will provide a high quality synthesis of OM for HBC from various evaluation aspects including liver function indexes, liver fibrosis indexes and Child-Pugh score, HBV DNA quantification, HBV DNA seroconversion rate, HBeAg seroconversion rate and adverse events incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The systematic review will provide evidence to assess the efficacy and safety of OM in the treatment of HBC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>PROSPERO CRD42018095275.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013482","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T18:09:10Z","timestamp":1544292550000},"page":"e13482","source":"Crossref","is-referenced-by-count":10,"title":["Oral oxymatrine for hepatitis B cirrhosis"],"prefix":"10.1097","volume":"97","author":[{"given":"Xiaotao","family":"Jiang","sequence":"first","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linling","family":"Xie","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihui","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishen","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haining","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Acupuncture and massage department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20240524","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R2-20240524","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7150\/ijms.2.17","article-title":"A practical approach to management of chronic hepatitis B","volume":"2","author":"Hu","year":"2005","journal-title":"Int J Med Sci"},{"key":"R3-20240524","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/918017","article-title":"Treatment of hepatitis B in decompensated liver cirrhosis","volume":"2011","author":"Guan","year":"2011","journal-title":"Int J Hepatol"},{"key":"R4-20240524","first-page":"606","article-title":"Cirrhosis of liver and portal vein thrombosis - a review article","volume":"23","author":"Debnath","year":"2014","journal-title":"Mymensingh Med J"},{"key":"R5-20240524","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1478-3231.2010.02255.x","article-title":"Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis","volume":"30","author":"Das","year":"2010","journal-title":"Liver Int"},{"key":"R6-20240524","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21615","article-title":"Management of patients with decompensated hepatitis B virus associated cirrhosis","volume":"14","author":"Zoulim","year":"2010","journal-title":"Liver Transplant"},{"key":"R7-20240524","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jhep.2004.11.014","article-title":"Management of patients with hepatitis B virus-induced cirrhosis","volume":"42","author":"Fung","year":"2005","journal-title":"J Hepatol"},{"key":"R8-20240524","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2013.13","article-title":"Hepatitis: Long-term therapy of chronic hepatitis B reverses cirrhosis","volume":"10","author":"Lok","year":"2013","journal-title":"Nat Rev Gastro Hepat"},{"key":"R9-20240524","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12718","article-title":"Long-term lamivudine treatment achieves regression of advanced liver fibrosis\/cirrhosis in patients with chronic hepatitis B","volume":"30","author":"Xu","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-20240524","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"R11-20240524","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrgastro.2011.57","article-title":"Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis","volume":"8","author":"Fink","year":"2011","journal-title":"Nat Rev Gastro Hepat"},{"key":"R12-20240524","first-page":"1","article-title":"Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol J"},{"key":"R13-20240524","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhep.2009.05.031","article-title":"Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension","volume":"51","author":"Manolakopoulos","year":"2009","journal-title":"J Hepatol"},{"key":"R14-20240524","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.3748\/wjg.v19.i40.6849","article-title":"Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis","volume":"19","author":"Li","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R15-20240524","first-page":"233","article-title":"Progress in the antiviral treatment of HBV-related cirrhosis","volume":"40","author":"Huang","year":"2013","journal-title":"J Fudan Univ Med Sci"},{"key":"R16-20240524","article-title":"Progress research on pharmacology and anti-tumour of kushenin","author":"Huang","year":"2009","journal-title":"Medical Recapitulate"},{"key":"R17-20240524","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/147323000903700515","article-title":"Inhibition of the replication of hepatitis B virus in vitro by oxymatrine","volume":"37","author":"Lin","year":"2009","journal-title":"J Int Med Res"},{"key":"R18-20240524","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3748\/wjg.v7.i1.49","article-title":"Inhibition of hepatitis B virus by oxymatrine in vivo","volume":"7","author":"Chen","year":"2001","journal-title":"World J Gastroenterol"},{"key":"R19-20240524","first-page":"20","article-title":"Effect of oxymatrine on fibroblastic proliferation and procollagen III mRNA expression","author":"Song","year":"1999","journal-title":"Acad J Second Mil Med Univ"},{"key":"R20-20240524","article-title":"Effect of kurarinone on serum TGF-\u03b21,TNF-\u03b1 and liver fibrosis index in patients with chronic hepatitis B","author":"Sun","year":"2003","journal-title":"Med J Chin People's Armed Police Forces"},{"key":"R21-20240524","first-page":"62","article-title":"Prevention and treatment of viral hepatitis","volume":"40","year":"2001","journal-title":"Chin J Intern Med"},{"key":"R22-20240524","first-page":"66","article-title":"The guidelines of prevention and treatment for chronic hepatitis B (2010 version)","volume":"3","year":"2011","journal-title":"Chin J Hepatol"},{"key":"R23-20240524","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R24-20240524","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive\u2014Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"Int J Epidemiol"},{"key":"R25-20240524","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"Int J Epidemiol"},{"key":"R26-20240524","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"Bmc Med Res Methodol"},{"key":"R27-20240524","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-2005-915649","article-title":"Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma","volume":"25","author":"Liaw","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R28-20240524","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2006-939752","article-title":"Hepatitis B virus-related cirrhosis: natural history and treatment","volume":"26","author":"Chu","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R29-20240524","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37590","article-title":"Natural history and prognosis of hepatitis B","volume":"23","author":"Fattovich","year":"2003","journal-title":"Semin Liver Dis"},{"key":"R30-20240524","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"R31-20240524","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.2007.128496","article-title":"Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years","volume":"57","author":"Fattovich","year":"2008","journal-title":"Gut"},{"key":"R32-20240524","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:03:26Z","timestamp":1716584606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00075"}},"subtitle":["A systematic review protocol"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013482","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}